Vericel to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Get Alerts VCEL Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York City on Tuesday, Sept. 26, 2017, at 3:00 p.m. EDT.
The presentation will be webcast live at http://wsw.com/webcast/ladenburg3/vcel and may be accessed from the news and events section of the Vericel website.
About Vericel CorporationVericel develops, manufactures, and markets expanded autologous cell therapies for the treatment of patients with serious diseases and conditions. The company markets two cell therapy products in the United States. Vericel is marketing MACI® (autologous cultured chondrocytes on porcine collagen membrane), an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Vericel is also marketing Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel is developing ixmyelocel-T, an autologous multicellular therapy intended to treat advanced heart failure due to ischemic dilated cardiomyopathy. For more information, please visit the company's website at www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel Corporation. © 2017 Vericel Corporation. All rights reserved.
Global Media Contacts:David SchullRusso Partners LLC+1 212-845-4271 (office)+1 858-717-2310 (mobile)[email protected]
Karen ChaseRusso Partners LLC+1 646-942-5627 (office)+1 917-547-0434 (mobile)[email protected]
Investor Contacts: Chad RubinThe Trout Group[email protected]+1 (646) 378-2947
Lee SternThe Trout Group[email protected]+1 (646) 378-2922
Source: Vericel CorporationSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawk Law Group’s Hawk Helps Hosts Third Annual Bookbag Bash, Providing Back-to-School Supplies to More Than 500 Augusta-Area Students
- Best 2 MOPP Medical Power Supplies: WECENT Promotes Evidence-Based Isolation Selection for Medical Device Sourcing
- Axiom Medical Emphasizes Early Injury Reporting to Strengthen Workplace Injury Case Management
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share